RVAC MEDICINES
RVAC Medicines is a mRNA platform company engaged in the research and development of innovative products such as vaccines for diseases.
RVAC MEDICINES
Social Links:
Industry:
Biotechnology Medical Product Research
Founded:
2021-01-01
Address:
Singapore, Central Region, Singapore
Country:
Singapore
Website Url:
http://www.rvacmed.com
Total Employee:
101+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
140 M USD
Investors List
C-Bridge Capital
C-Bridge Capital investment in Series B - RVAC Medicines
Pavilion Capital
Pavilion Capital investment in Series B - RVAC Medicines
GS Holdings
GS Holdings investment in Series B - RVAC Medicines
EDBI
EDBI investment in Series B - RVAC Medicines
Official Site Inspections
http://www.rvacmed.com
- Host name: ec2-13-214-56-45.ap-southeast-1.compute.amazonaws.com
- IP address: 13.214.56.45
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "RVAC Medicines"
RVAC Medicines - Crunchbase Company Profile
Contact Email [email protected] RVAC Medicines is an mRNA platform company with a pipeline of novel products covering a wide range of disease areas. The company is building a pipeline of novel mRNA vaccines and …See details»
RVAC Medicines Company Profile 2024: Valuation, …
RVAC Medicines General Information Description. Developer of mRNA platform designed to build a diverse pipeline of innovative medicines. The company provides end-to-end GMP manufacturing capabilities, MSAT infrastructure …See details»
RVAC Medicines Company Profile | Management and Employees …
RVAC Medicines Profile and History. RVAC Medicines is an mRNA platform company. We are building a diverse pipeline of innovative medicines. Our leading asset, a COVID-19 vaccine, is …See details»
RVAC Medicines - Drug pipelines, Patents, Clinical trials - Synapse
Www.rvacmed.com. Startups | Private Company | 2021 | Singapore | 50-100 | www.rvacmed.com. Last update 01 Nov 2024. Overview. Pipeline. Deal. Translational Medicine. Profit. ... Parsey …See details»
RVAC Medicines - VentureRadar
"RVAC Medicines is an mRNA platform company. We are building a diverse pipeline of innovative medicines. Our leading asset, a COVID-19 vaccine, is quickly moving into clinical trials and is …See details»
Rvac Medicines (us), Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Rvac Medicines (us), Inc. of Waltham, MA. Get the latest business insights from Dun & Bradstreet.See details»
RVAC Medicines - Products, Competitors, Financials, Employees ...
About RVAC Medicines. RVAC Medicines is an mRNA platform company that builds a diverse pipeline of medicines. Its leading asset, a COVID-19 vaccine, is quickly moving into clinical …See details»
RVAC Medicines - LinkedIn
RVAC Medicines Biotechnology A mRNA platform company with a pipeline of innovative products that covers a range of disease areas.See details»
RVAC MEDICINES PTE. LTD. (202126749W) - Singapore Company
Aug 2, 2021 RVAC MEDICINES PTE. LTD. Registration No. / Unique Entity Number: 202126749W issued by Accounting And Corporate Regulatory Authority RVAC MEDICINES …See details»
RVAC Medicines - VentureRadar
RVAC Medicines is an mRNA platform company. We are building a diverse pipeline of innovative medicines. Our leading asset, a COVID-19 vaccine, is... ... Find out more ...See details»
RVAC Medicines Company Profile: Overview and Full News Analysis
Rvacmed.com. Overview: RVAC Medicines. RVAC Medicines is a pharmaceutical company based in the Central Region, specializing in the development and production of innovative medicines …See details»
RVAC Medicines Pte Ltd. (RVAC Medicines Pte Ltd.) - 药物管线_专 …
PISCATAWAY, N.J. and SINGAPORE, Feb. 22, 2023 /PRNewswire/ -- GenScript ProBio, a leading global Contract Development and Manufacturing Organization (CDMO), and RVAC …See details»
RVAC Medicines - Company Profile - Tracxn
Dec 11, 2024 RVAC Medicines - Developer of therapeutics to treat infectious and other diseases. This company is not active anymore. Raised a total funding of $140M over 1 round …See details»
RVAC Medicines - Medtech Alert
Apr 27, 2022 RVAC Medicines is an mRNA platform company. We are building a diverse pipeline of innovative medicines. Our leading asset, a COVID-19 vaccine, is quickly moving …See details»
RVAC Medicines: Employee Directory | ZoomInfo.com
Feb 4, 2024 RVAC Medicines is an mRNA platform company. We are building a diverse pipeline of innovative medicines. Our leading asset, a COVID-19 vaccine, is quickly moving into clinical …See details»
CEPI partners with RVAC Medicines to accelerate manufacturing of …
Jun 27, 2023 Leveraging its mRNA technology and strategic partnerships, the company is building a pipeline of novel mRNA vaccines and therapeutics to address unmet medical needs. …See details»
RVAC MEDICINES AND A*STAR TO BUILD CAPABILITIES FOR …
Nov 21, 2022 Headquartered in Singapore, CBC Group ("CBC") is Asia's largest healthcare-dedicated asset management firm, focusing on platform-building, buyout, credit/royalty, and …See details»
RVAC Medicines Initiates First-in-Human Clinical ... - Markets Insider
Sep 21, 2022 For more information, please visit www.rvacmed.com. About CBC. CBC Group, Asia's largest healthcare-dedicated asset management firm, focuses on platform-building, …See details»
RVAC Medicines Initiates First-in-Human Clinical Trials for mRNA …
Sep 22, 2022 For more information, please visit www.rvacmed.com. About CBC. CBC Group, Asia's largest healthcare-dedicated asset management firm, focuses on platform-building, …See details»
RVAC Medicines Initiates First-in-Human Clinical Trials for
SINGAPORE, Sept. 21, 2022 /PRNewswire/ -- RVAC Medicines Pte. Ltd., a messenger RNA (mRNA) technology platform company incubated by CBC Group in 2021, announced today …See details»